Inventor · disambiguated record
Edward T. Maggio
Also filed as: MAGGIO EDWARD T · ZUK ROBERT F
58 granted patents·46 pending applications·3,397 citations·filing 1977–2025
99Inventor score
Files withAEGIS THERAPEUTICS LLC33MAGGIO EDWARD T24NEURELIS INC8AEGIS THERAPEUTICS INC5HALE BIOPHARMA VENTURES LLC5
Top patents by PatentIndex Score
104 records- 0199US4277437AKit for carrying out chemically induced fluorescence immunoassaySYVA CO·Filed 1979·Granted Jul 7, 1981·1.3k cites·4 claims
- 0299US4233402AReagents and method employing channelingSYVA CO·Filed 1978·Granted Nov 11, 1980·450 cites·44 claims
- 0399US4208479ALabel modified immunoassaysSYVA·Filed 1977·Granted Jun 17, 1980·416 cites·37 claims
- 0498US10265402B2Absorption enhancers for drug administrationAEGIS THERAPEUTICS LLC·Filed 2018·Granted Apr 23, 2019·13 cites·7 claims
- 0598US8226949B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2009·Granted Jul 24, 2012·32 cites·48 claims
- 0698US8133863B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2009·Granted Mar 13, 2012·38 cites·37 claims
- 0798US7998927B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2008·Granted Aug 16, 2011·38 cites·79 claims
- 0897US11918655B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Mar 5, 2024·5 cites·44 claims
- 0997US11717571B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2022·Granted Aug 8, 2023·6 cites·30 claims
- 1097US11191838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
- 1197US10576156B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2018·Granted Mar 3, 2020·10 cites·6 claims
- 1297US9895444B2Compositions for drug administrationAEGIS THERAPEUTICS INC·Filed 2013·Granted Feb 20, 2018·30 cites·18 claims
- 1397US7425542B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS INC·Filed 2006·Granted Sep 16, 2008·66 cites·15 claims
- 1497US4220450AChemically induced fluorescence immunoassaySYVA·Filed 1978·Granted Sep 2, 1980·118 cites·32 claims
- 1596US12324838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Jun 10, 2025·3 cites·11 claims
- 1696US12268664B1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2024·Granted Apr 8, 2025·3 cites·18 claims
- 1796US11744895B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2021·Granted Sep 5, 2023·3 cites·26 claims
- 1896US10682414B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2019·Granted Jun 16, 2020·10 cites·20 claims
- 1995US11173209B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2019·Granted Nov 16, 2021·6 cites·10 claims
- 2095US8927497B2Absorption enhancers for intranasal administrationMAGGIO EDWARD T·Filed 2012·Granted Jan 6, 2015·11 cites·5 claims
- 2195US8772231B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2010·Granted Jul 8, 2014·12 cites·34 claims
- 2295US8268791B2Alkylglycoside compositions for drug administrationMAGGIO EDWARD T·Filed 2008·Granted Sep 18, 2012·36 cites·15 claims
- 2394US12337061B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2022·Granted Jun 24, 2025·2 cites·62 claims
- 2494US11241414B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Feb 8, 2022·2 cites·18 claims
- 2594US8530463B2Multimodal particulate formulationsCARTT STEVE·Filed 2008·Granted Sep 10, 2013·34 cites·24 claims
- 2694US8173594B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2009·Granted May 8, 2012·13 cites·39 claims
- 2794US8076290B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2007·Granted Dec 13, 2011·12 cites·15 claims
- 2893US12324852B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Jun 10, 2025·2 cites·31 claims
- 2993US11793786B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Oct 24, 2023·2 cites·27 claims
- 3093US9642913B2Pharmaceutical composition including alkyl glycoside and an anti-seizure agentAEGIS THERAPEUTICS LLC·Filed 2014·Granted May 9, 2017·13 cites·7 claims
- 3193US8846044B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2012·Granted Sep 30, 2014·7 cites·48 claims
- 3293US8642564B2Compositions for drug administrationMAGGIO EDWARD T·Filed 2008·Granted Feb 4, 2014·11 cites·16 claims
- 3392US10046025B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2016·Granted Aug 14, 2018·3 cites·18 claims
- 3492US8440631B2Compositions for drug administrationMAGGIO EDWARD T·Filed 2009·Granted May 14, 2013·7 cites·13 claims
- 3592US8084022B2Stabilizing alkylglycoside compositions and methods thereofMAGGIO EDWARD T·Filed 2008·Granted Dec 27, 2011·19 cites·34 claims
- 3692US4397956AMeans for monitoring the status of control of ketoacidosis-prone diabeticsMAGGIO EDWARD T·Filed 1981·Granted Aug 9, 1983·56 cites·8 claims
- 3791US8551468B2Absorption enhancers for intranasal interferon administrationMAGGIO EDWARD T·Filed 2008·Granted Oct 8, 2013·4 cites·7 claims
- 3891US5079142AOrthogonal flow immunoassays and devicesSYNBIOTICS CORP·Filed 1987·Granted Jan 7, 1992·107 cites·13 claims
- 3990US9446134B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2014·Granted Sep 20, 2016·4 cites·25 claims
- 4089US8895546B2Administration of benzodiazepine compositionsCARTT STEVE·Filed 2012·Granted Nov 25, 2014·10 cites·22 claims
- 4189US4385126ADouble tagged immunoassayINT DIAGNOSTIC TECH·Filed 1979·Granted May 24, 1983·81 cites·6 claims
- 4288US4828981AImmunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagentsSYNBIOTICS CORP·Filed 1983·Granted May 9, 1989·56 cites·22 claims
- 4386US11458091B2Compositions and methods for the treatment of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2017·Granted Oct 4, 2022·2 cites·15 claims
- 4484US9763876B2Administration of benzodiazepine compositionsHALE BIOPHARMA VENTURES LLC·Filed 2014·Granted Sep 19, 2017·7 cites·36 claims
- 4584US9283280B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2013·Granted Mar 15, 2016·2 cites·20 claims
- 4684US8883728B2Intranasal administration of active agents to the central nervous systemMAGGIO EDWARD T·Filed 2010·Granted Nov 11, 2014·5 cites·6 claims
- 4784US7392199B2Diagnosing inapparent diseases from common clinical tests using Bayesian analysisQUEST DIAGNOSTICS INVEST INC·Filed 2002·Granted Jun 24, 2008·68 cites·44 claims
- 4883US2025281394A1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2025·Application pending·0 cites
- 4983US2025262305A1Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 5083US2023104144A1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Edward T. Maggio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →